Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 2
2014 1
2015 1
2017 2
2018 2
2019 1
2020 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT).
Bechdolf A, Müller H, Hellmich M, de Millas W, Falkai P, Gaebel W, Gallinat J, Hasan A, Heinz A, Janssen B, Juckel G, Karow A, Krüger-Özgürdal S, Lambert M, Maier W, Meyer-Lindenberg A, Pützfeld V, Rausch F, Schneider F, Stützer H, Wobrock T, Wagner M, Zink M, Klosterkötter J. Bechdolf A, et al. Among authors: kruger ozgurdal s. Schizophr Bull. 2023 Jul 4;49(4):1055-1066. doi: 10.1093/schbul/sbad029. Schizophr Bull. 2023. PMID: 37021666 Free PMC article. Clinical Trial.
Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study.
Martini J, Bröckel KL, Leopold K, Berndt C, Sauer C, Maicher B, Juckel G, Krüger-Özgürdal S, Fallgatter AJ, Lambert M, Bechdolf A, Reif A, Matura S, Biere S, Kittel-Schneider S, Stamm T, Bermpohl F, Kircher T, Falkenberg I, Jansen A, Dannlowski U, Correll CU, Fusar-Poli P, Hempel LM, Mikolas P, Ritter P, Bauer M, Pfennig A. Martini J, et al. Among authors: kruger ozgurdal s. Eur Neuropsychopharmacol. 2024 Jan;78:43-53. doi: 10.1016/j.euroneuro.2023.10.001. Epub 2023 Oct 30. Eur Neuropsychopharmacol. 2024. PMID: 37913697 Free article.
Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms.
Müller H, de Millas W, Gaebel W, Herrlich J, Hasan A, Janssen B, Juckel G, Karow A, Kircher T, Kiszkenow-Bäker S, Klingberg S, Klosterkötter J, Krüger-Özgürdal S, Lambert M, Lautenschlager M, Maier W, Michel TM, Mehl S, Müller BW, Pützfeld V, Rausch F, Riedel M, Sartory G, Schneider F, Wagner M, Wiedemann G, Wittorf A, Wobrock T, Wölwer W, Zink M, Bechdolf A. Müller H, et al. Among authors: kruger ozgurdal s. Early Interv Psychiatry. 2018 Dec;12(6):1157-1165. doi: 10.1111/eip.12433. Epub 2017 May 19. Early Interv Psychiatry. 2018. PMID: 28524542
The bipolar disorder prodrome revisited: Is there a symptomatic pattern?
Zeschel E, Correll CU, Haussleiter IS, Krüger-Özgürdal S, Leopold K, Pfennig A, Bechdolf A, Bauer M, Juckel G. Zeschel E, et al. Among authors: kruger ozgurdal s. J Affect Disord. 2013 Nov;151(2):551-560. doi: 10.1016/j.jad.2013.06.043. Epub 2013 Aug 8. J Affect Disord. 2013. PMID: 23932736
Clinical high risk for psychosis: gender differences in symptoms and social functioning.
Rietschel L, Lambert M, Karow A, Zink M, Müller H, Heinz A, de Millas W, Janssen B, Gaebel W, Schneider F, Naber D, Juckel G, Krüger-Özgürdal S, Wobrock T, Wagner M, Maier W, Klosterkötter J, Bechdolf A; PREVENT study group. Rietschel L, et al. Among authors: kruger ozgurdal s. Early Interv Psychiatry. 2017 Aug;11(4):306-313. doi: 10.1111/eip.12240. Epub 2015 Mar 24. Early Interv Psychiatry. 2017. PMID: 25808791
Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study.
Leopold K, Bauer M, Bechdolf A, Correll CU, Holtmann M, Juckel G, Lambert M, Meyer TD, Pfeiffer S, Kittel-Schneider S, Reif A, Stamm TJ, Rottmann-Wolf M, Mathiebe J, Kellmann EL, Ritter P, Krüger-Özgürdal S, Karow A, Sondergeld LM, Roessner V, Sauer C, Pfennig A. Leopold K, et al. Among authors: kruger ozgurdal s. Bipolar Disord. 2020 Aug;22(5):517-529. doi: 10.1111/bdi.12894. Epub 2020 Mar 13. Bipolar Disord. 2020. PMID: 32112496 Clinical Trial.
Pathways to care in subjects at high risk for psychotic disorders - a European perspective.
von Reventlow HG, Krüger-Özgürdal S, Ruhrmann S, Schultze-Lutter F, Heinz A, Patterson P, Heinimaa M, Dingemans P, French P, Birchwood M, Salokangas RK, Linszen D, Morrison A, Klosterkötter J, Juckel G. von Reventlow HG, et al. Among authors: kruger ozgurdal s. Schizophr Res. 2014 Feb;152(2-3):400-7. doi: 10.1016/j.schres.2013.11.031. Epub 2013 Dec 27. Schizophr Res. 2014. PMID: 24377700
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, Krüger-Özgürdal S, Wobrock T, Riedel M, Klosterkötter J; PREVENT study group. Bechdolf A, et al. Among authors: kruger ozgurdal s. Schizophr Bull. 2011 Sep;37 Suppl 2:S111-21. doi: 10.1093/schbul/sbr083. Schizophr Bull. 2011. PMID: 21860040 Free PMC article. Clinical Trial.